Hypothesis

Age‑related decline in enteric nervous system (ENS) activity initiates a cascade that simultaneously triggers genomic instability, epigenetic alteration, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication, positioning the ENS as an upstream controller of the hallmarks of aging.

Mechanistic Rationale

• The ENS communicates with the brain via vagal afferents; reduced vagal tone lowers acetylcholine release in the gut wall, decreasing anti‑inflammatory signaling and allowing microbiota‑driven inflammation to rise ([6]).
• Gut inflammation activates enterochromaffin cells and immune cells, releasing cytokines that reach the circulation and suppress mitochondrial complex I activity in peripheral tissues, increasing ROS production ([2]).
• Mitochondrial ROS damage nuclear DNA, contributing to genomic instability, and also inhibit export of acetyl‑CoA from mitochondria to the nucleus, leading to reduced histone acetylation and a shift toward a repressive epigenetic state ([3]).
• Epigenetic changes alter expression of DNA‑repair genes and senescence‑associated secretory phenotype (SASP) factors, reinforcing cellular senescence and stem cell exhaustion ([1], [5]).
• Senescent cells secrete IL‑6 and other cytokines that further aggravate gut inflammation, creating a bidirectional loop that amplifies ENS degeneration ([5], [6]).
• It's expected that restoring ENS vagal signaling (e.g., via serotonergic agonists or electrical stimulation) will boost acetylcholine, dampen inflammation, improve mitochondrial acetyl‑CoA flux, and reset epigenetic marks, thereby attenuating multiple hallmarks simultaneously.

Testable Predictions

1. In aged mice, chemogenetic inhibition of ENS neurons will accelerate the appearance of all seven hallmarks compared with controls.
2. Conversely, optogenetic activation of ENS vagal pathways in aged mice will reduce mitochondrial ROS, lower epigenetic age (as measured by DNA methylation clocks), decrease SASP factors, and improve stem cell colony‑forming units within two weeks.
3. Pharmacological blockade of gut‑derived cytokines (e.g., anti‑IL‑6) will blunt the hallmark acceleration caused by ENS inhibition, indicating that inflammation mediates the downstream effects.
4. Transplanting feces from young donors into ENS‑suppressed aged mice will not rescue hallmarks unless vagal signaling is intact, showing that microbiota changes act downstream of ENS‑driven inflammation.

Experimental Design

• Use Thy1‑ChR2 mice to allow optogenetic stimulation of ENS neurons; implant fiberoptic probes targeting the myenteric plexus.
• Cohorts: young (3 mo), aged (24 mo) untreated, aged + ENS inhibition (hM4Di DREADD + CLO), aged + ENS activation (ChR2 + 473 nm light, 20 Hz, 5 min daily), and aged + ENS activation + anti‑IL‑6 antibody.
• Measure hallmarks weekly: mitochondrial ROS (MitoSOX), nuclear γH2AX foci, epigenetic age (Horvath mouse clock), SASP cytokine panel (ELISA), stem cell colonies (crypt assay), and intestinal permeability (FITC‑dextran).
• Behavioral readouts: rotarod performance and cognitive maze to link physiological changes to functional outcomes.
• Statistical analysis: two‑way ANOVA with post‑hoc Tukey; n = 10 per group to detect 20 % effect size with power > 0.8.
• We're measuring coordinated changes across at least four hallmarks; if ENS manipulation fails to produce such changes, the hypothesis can't be supported and is falsified.